140 related articles for article (PubMed ID: 8684496)
21. Acquired blepharoptosis secondary to essential blepharospasm.
Bodker FS; Olson JJ; Putterman AM
Ophthalmic Surg; 1993 Aug; 24(8):546-50. PubMed ID: 8233320
[TBL] [Abstract][Full Text] [Related]
22. Control of eyelid retraction associated with Graves' disease with botulinum A toxin.
Biglan AW
Ophthalmic Surg; 1994 Mar; 25(3):186-8. PubMed ID: 8196925
[TBL] [Abstract][Full Text] [Related]
23. Botulinum A toxin injection in patients with facial nerve palsy.
Smet-Dieleman H; Van de Heyning PH; Tassignon MJ
Acta Otorhinolaryngol Belg; 1993; 47(3):359-63. PubMed ID: 8213150
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
[TBL] [Abstract][Full Text] [Related]
25. Blepharoptosis and external ophthalmoplegia associated with long-term antiretroviral therapy.
Dinges WL; Witherspoon SR; Itani KM; Garg A; Peterson DM
Clin Infect Dis; 2008 Sep; 47(6):845-52. PubMed ID: 18687051
[TBL] [Abstract][Full Text] [Related]
26. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
Reddy UP; Woodward JA
Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
[TBL] [Abstract][Full Text] [Related]
27. Treatment of ptosis as a complication of botulinum toxin injection.
Omoigui S; Irene S
Pain Med; 2005; 6(2):149-51. PubMed ID: 15773880
[TBL] [Abstract][Full Text] [Related]
28. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
Scheinfeld N
Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
[TBL] [Abstract][Full Text] [Related]
29. Apraclonidine in the treatment of ptosis.
Wijemanne S; Vijayakumar D; Jankovic J
J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
[TBL] [Abstract][Full Text] [Related]
30. Unilateral ptosis: a rare presentation.
Farooq S; Dukht U; Jaffar S
J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140
[TBL] [Abstract][Full Text] [Related]
31. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
Bulstrode NW; Grobbelaar AO
Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
[TBL] [Abstract][Full Text] [Related]
32. [Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients].
Tabashnikova TV; Serova NK; Shimanskiĭ VN; Grigor'eva NN
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):43-8; discussion 48. PubMed ID: 23033592
[TBL] [Abstract][Full Text] [Related]
33. Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasms and eyelid apraxia.
Verhulst S; Smet H; De Wilde F; Tassignon MJ
Bull Soc Belge Ophtalmol; 1994; 252():51-3. PubMed ID: 7894756
[TBL] [Abstract][Full Text] [Related]
34. Bell's palsy: management of sequelae using EMG rehabilitation, botulinum toxin, and surgery.
May M; Croxson GR; Klein SR
Am J Otol; 1989 May; 10(3):220-9. PubMed ID: 2750869
[TBL] [Abstract][Full Text] [Related]
35. Sequelae of botulinum toxin injection.
Lingua RW
Am J Ophthalmol; 1985 Aug; 100(2):305-7. PubMed ID: 4025471
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
[TBL] [Abstract][Full Text] [Related]
37. Steroid-induced ptosis: case studies and histopathologic analysis.
Song A; Carter KD; Nerad JA; Boldt C; Folk J
Eye (Lond); 2008 Apr; 22(4):491-5. PubMed ID: 17220825
[TBL] [Abstract][Full Text] [Related]
38. Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases.
Ferreira MC; Salles AG; Gimenez R; Soares MF
Aesthetic Plast Surg; 2004; 28(6):441-4. PubMed ID: 15580431
[TBL] [Abstract][Full Text] [Related]
39. Pathological changes in levator palpebrae superioris muscle treated with botulinum toxin in a case of carotico-cavernous fistula.
Adams GG; Dilly PN
Br J Ophthalmol; 1991 Mar; 75(3):181-4. PubMed ID: 2012790
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study.
Bertolasi L; Priori A; Tomelleri G; Bongiovanni LG; Fincati E; Simonati A; De Grandis D; Rizzuto N
Ann Neurol; 1997 Feb; 41(2):181-6. PubMed ID: 9029067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
